S L Hale
Overview
Explore the profile of S L Hale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas R, Dunstan F, Luzio S, Roy Chowdury S, Hale S, North R, et al.
BMJ
. 2012 Feb;
344:e874.
PMID: 22362115
Objectives: To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode...
2.
Hale S, Kloner R
Heart Dis
. 2002 Apr;
3(6):351-6.
PMID: 11975818
The aim of this study was to test whether myocardial infarct size reduction would be optimized by combining three known effective therapies: cariporide, regional hypothermia, and ischemic preconditioning (CHIP). Before...
3.
Hale S, Kloner R
Heart Dis
. 2002 Apr;
3(5):293-6.
PMID: 11975808
Some epidemiologic analyses suggest that moderate drinking of alcohol may have beneficial effects on the heart. An experimental in vitro study also indicated that acute alcohol administration may precondition myocardium...
4.
Hale S, Kloner R
J Stud Alcohol
. 2002 Feb;
62(6):730-5.
PMID: 11838907
Objective: Resveratrol is a potent anti-inflammatory and anti-oxidant flavinoid found in red wine. Resveratrol has been shown to improve ventricular function and decrease lactic dehydrogenase release after ischemia in rats....
5.
Dow J, Hale S, Kloner R
J Cardiovasc Pharmacol
. 2001 Jun;
37(6):662-7.
PMID: 11392462
Several observational and epidemiologic analyses suggest that moderate drinking of alcohol (usually two drinks per day) may have beneficial effects on the heart. Specifically it may reduce the incidence of...
6.
Baxter G, Hale S, Miki T, Kloner R, Cohen M, Downey J, et al.
Cardiovasc Drugs Ther
. 2001 Apr;
14(6):607-14.
PMID: 11300361
Adenosine A1 receptor agonists given prior to myocardial ischemia limit ischemic injury in several species. However, the ability of adenosine receptor agonists to limit infarct size when given at reperfusion...
7.
Hale S, Kloner R
Am J Physiol Heart Circ Physiol
. 2000 Nov;
279(6):H2673-7.
PMID: 11087220
We tested if combining treatment with cariporide, an Na(+)/H(+) exchange inhibitor, and diazoxide, a mitochondrial ATP-sensitive K(+) (K(ATP)) channel opener, would reduce myocardial infarct size (IS) to a greater extent...
8.
Schwarz E, Somoano Y, Hale S, Kloner R
J Thromb Thrombolysis
. 2000 Sep;
10(2):181-7.
PMID: 11005940
Measurements of infarct size by use of tripenyltetrazoliumchloride (TTC) is a widely accepted method used to delineate the extent of myocardial necrosis following coronary occlusion and reperfusion in various animal...
9.
Hale S, Kloner R
J Mol Cell Cardiol
. 2000 Mar;
32(3):505-10.
PMID: 10731448
Determinants of infarct size in the rabbit heart include risk zone size, regional myocardial blood flow (RMBF), temperature and duration of ischemia. However, other factors might contribute, such as the...
10.
Hale S, Kloner R
Am J Physiol
. 1999 Jun;
276(6):H2029-34.
PMID: 10362684
This study tests whether combining regional hypothermia and ischemic preconditioning (IP) provides greater myocardial protection during prolonged coronary artery occlusion (CAO) than either intervention alone, and whether increasing the duration...